# Abtrace

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/abtrace

- Industry: Software
- Headquarters: London, UK
- Website: www.abtrace.co
- Total disclosed funding: $1.5M
- Latest round: Seed (May 7, 2021)
- Investors on record: 3

## About

Founded in 2018 and based in London, UK, Abtrace Ltd. operates as an AI-based solution for medical expertise. The company was co-founded by CEO Umar Ahmad, COO Helder Soares, and CCO Cristina Correia. In August 2021, Abtrace raised EUR 2.4 million in Seed funding led by Faber.

The company uses machine learning to provide digital solutions that allow healthcare institutions to react and manage the patient’s current diseases and to recognize clinical signs of new conditions. Abtrace has built an AI tool that can plug into the Electronic Health Record (EHR) database and identify which tests or treat patients with a long-term health condition needs or might benefit from. The software allows GPs and healthcare assistants (HCAs) to make informed decisions, automate key elements of disease monitoring, and ensure patients receive consistent, effective care.

The company plans to use its funding from August 2021 to roll the technology out to new GP practices across the UK and expand its engineering and data, science teams.

## Funding rounds

- Seed, May 7, 2021, $1.5M — Faber Ventures, Innovate UK, Ganexa Capital

## Investors

- Faber Ventures (https://capitalatlas.ai/funds/faber-ventures) — Seed
- Innovate UK — Seed
- Ganexa Capital — Seed